PACSEC3 v. Bitdefender: Firewall Patent Suit Dismissed With Prejudice in 84 Days
PACSEC3, LLC filed an infringement action against Bitdefender, Inc. in the Western District of Texas asserting US7523497B2, a patent covering firewall systems. The case resolved in just 84 days when PACSEC3 voluntarily dismissed all claims with prejudice before Bitdefender had filed any answer or summary judgment motion.
A Firewall Patent Lawsuit That Closed Before Bitdefender Even Answered
On June 20, 2025, PACSEC3, LLC — represented by William P. Ramey III of Ramey LLP — filed suit against Bitdefender, Inc. in the Western District of Texas (Case No. 7:25-cv-00285), asserting infringement of US7523497B2, a patent directed at firewall systems. Bitdefender is a well-known cybersecurity vendor whose endpoint protection and network security products are deployed globally, making them a commercially plausible target for a firewall-related patent assertion.
The case terminated on September 12, 2025, when PACSEC3 filed a Notice of Voluntary Dismissal With Prejudice under Fed. R. Civ. P. 41(a)(1)(A)(i). Because Bitdefender had not yet served an answer or a motion for summary judgment, the notice was self-effectuating — no court order was required to close the case. The court confirmed termination and directed each party to bear its own costs, with all pending motions denied as moot. Critically, dismissal with prejudice extinguishes PACSEC3’s right to reassert these specific claims against Bitdefender.
An 84-day lifespan is strikingly short, even by the standards of pre-answer patent dismissals. The absence of any Bitdefender counsel on record and the timing — before any substantive response — suggests the parties may have reached a private resolution, though the public record is silent on any financial terms. The with-prejudice designation is a meaningful concession by PACSEC3: it permanently bars re-litigation of these claims against this defendant, which is atypical if the dismissal were purely tactical.
Filing to Voluntary dismissal in 84 days
84 days — well below the median patent case lifespan of 2–3 years in W.D. Texas
Dismissed with prejudice: what the Rule 41 termination means for each party
Rule 41(a)(1)(A)(i): Self-Effectuating Dismissal Before Any Answer
Under Fed. R. Civ. P. 41(a)(1)(A)(i), a plaintiff may voluntarily dismiss an action without a court order by filing a notice before the defendant serves an answer or motion for summary judgment. Because Bitdefender had not yet done either, PACSEC3’s notice was immediately operative — the court’s subsequent order was confirmatory, not constitutive. The with-prejudice election, however, goes beyond the rule’s default: Rule 41(a)(1)(B) makes a voluntary dismissal without prejudice unless the notice itself states otherwise.
Fed. R. Civ. P. 41(a)(1)(A)(i)With Prejudice: PACSEC3 Cannot Refile These Claims Against Bitdefender
A dismissal with prejudice operates as a final adjudication on the merits under Rule 41(a)(1)(B), permanently barring PACSEC3 from reasserting the same infringement claims based on US7523497B2 against Bitdefender. This is a materially stronger outcome for Bitdefender than a without-prejudice dismissal, which would have left the door open to re-filing. The public record does not disclose whether any consideration was exchanged — a licensing payment or covenant not to sue would be commercially consistent with the with-prejudice election.
Claim preclusion appliesPACSEC3 Surrenders Its Litigation Position Against This Defendant
By voluntarily dismissing with prejudice, PACSEC3 has permanently closed its enforcement avenue against Bitdefender under these claims. This does not, however, affect the validity or enforceability of US7523497B2 itself — the patent survives and may be asserted against other parties. Whether PACSEC3 extracted any value before dismissing (e.g. a license fee, a covenant payment, or simply avoided litigation cost) remains unknown from the public record. For portfolio strategy purposes, the case suggests the assertion may have encountered early commercial or legal obstacles.
Patent remains in forceBitdefender Walks Away Clean — But US7523497B2 Remains a Live Risk Sector-Wide
Bitdefender achieves a clean exit: no consent judgment, no injunction, no admitted infringement, and claim preclusion against PACSEC3 specifically. However, US7523497B2 is not invalidated by this outcome. Other cybersecurity vendors whose products implement firewall architectures covered by this patent should treat it as an active enforcement risk. PACSEC3’s willingness to file — and then quickly settle or retreat — is consistent with a portfolio assertion strategy targeting multiple defendants sequentially.
Sector-wide FTO risk remainsFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | PACSEC3, LLC | Company | Patent assertion entity — holder of US7523497B2 covering firewall systemsSearch in Eureka ↗ |
| Defendant | Bitdefender, Inc. | Company | Bitdefender, Inc. — global cybersecurity vendor, endpoint and network security productsSearch in Eureka ↗ |
| Plaintiff counsel | William P. Ramey , III | Attorney | Counsel for PACSEC3, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Ramey LLP | Law Firm | Representing PACSEC3, LLCSearch in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Texas Western District CourtSearch in Eureka ↗ |
Official order — verbatim text
The court’s order confirms that PACSEC3’s Rule 41(a)(1)(A)(i) notice was self-effectuating — a procedural posture that requires no merits adjudication and no judicial approval. The with-prejudice designation in the notice itself is the operative legal fact: it converts what would otherwise be a default without-prejudice dismissal into a claim-preclusive termination. Notably, the court ordered each party to bear its own costs, suggesting no fee-shifting motion was filed or pursued by Bitdefender — consistent with a negotiated exit rather than a contested dismissal.
US7523497B2 — Firewall Systems Patent
US7523497B2 (application no. US10/841064) is a granted US patent directed at firewall systems — a foundational category of network security technology that governs how traffic is inspected, filtered, and controlled at network boundaries. The patent’s application number suggests it was filed in the mid-2000s, a period of rapid evolution in stateful inspection and perimeter defence architectures. The ‘497 patent’s claims likely capture implementation methods or system configurations that remain relevant to modern endpoint and network protection products.
For the cybersecurity sector, firewall-related patents carry persistent commercial relevance because the underlying technical functions — packet filtering, stateful inspection, access control rule engines — are embedded in virtually every enterprise security product. PACSEC3’s willingness to assert this patent against a major vendor like Bitdefender suggests confidence in the patent’s claim breadth. Any vendor shipping products that implement firewall functionality, whether as a standalone appliance, a software agent, or a cloud-delivered service, should evaluate their exposure to this patent’s claim scope before receiving an assertion letter.
Should you run an FTO analysis against US7523497B2?
If your organisation develops, sells, or integrates firewall systems, endpoint security software, unified threat management platforms, or next-generation firewall products, US7523497B2 is a patent that warrants a formal freedom-to-operate assessment. The fact that PACSEC3 filed against Bitdefender — and obtained a with-prejudice dismissal before trial — does not eliminate the risk for other market participants. The patent remains in force, and the assertion pattern suggests active enforcement intent.
PatSnap Eureka’s FTO Search Agent can accelerate this analysis: map US7523497B2’s independent claims against your product architecture, surface related continuations or divisionals in PACSEC3’s portfolio, identify prior art that may support an IPR petition, and benchmark comparable litigation outcomes in the W.D. Texas patent docket. R&D and IP teams can run this analysis before product launch or in response to a cease-and-desist — dramatically compressing the time from exposure identification to clearance decision.
Run a freedom-to-operate analysis on US7523497B2 to assess your product’s exposure
Run FTO in Eureka →Similar Firewall & Network Security Patent Cases in W.D. Texas
Explore comparable firewall and cybersecurity patent infringement actions filed in the Western District of Texas, including related Ramey LLP assertions and US7523497B2 portfolio cases.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable Firewall systems-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedPACSEC3, LLC’s broader IP enforcement history
PACSEC3, LLC’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the cybersecurity IP enforcement landscape
A quick with-prejudice exit in W.D. Texas often signals a private deal — or a reassessment of claim strength before costs escalate.
Pre-answer dismissals in patent cases frequently mask licensing activity
When a plaintiff voluntarily dismisses with prejudice before the defendant has even filed an answer, it typically signals one of two things: a confidential license agreement, or a decision that the economics of litigation no longer favour enforcement. Either way, the underlying patent — US7523497B2 — is not extinguished. Competitors in the firewall and endpoint security space should not treat Bitdefender’s clean exit as a signal that the patent lacks teeth.
Ramey LLP’s assertion pattern warrants monitoring by cybersecurity vendors
William P. Ramey III and Ramey LLP are a frequently-appearing plaintiff firm in W.D. Texas patent assertions. Companies in the network security and firewall space should monitor PACSEC3’s broader portfolio activity and any related entities. The rapid filing-and-dismissal cycle here is consistent with a volume assertion strategy where early resolution — on any terms — is the primary objective.
US7523497B2 claim scope analysis: where competitor exposure concentrates
Understanding the specific claim language of US7523497B2 is critical for any vendor whose products inspect, filter, or route network traffic. The patent’s application date context and prosecution history may reveal narrowing amendments that limit — or expand — its reach beyond conventional firewall architectures. A targeted claim mapping against stateful packet inspection and next-gen firewall products is warranted.
PACSEC3’s portfolio: identifying the next likely assertion targets
Patent assertion entities rarely hold a single patent. Mapping PACSEC3’s full IP portfolio — including related applications, continuations, and assignments — can reveal which other cybersecurity product categories are within the enforcement perimeter. Companies with exposure in network security, endpoint protection, or unified threat management should conduct this analysis before a notice letter arrives.
PACSEC3 v Bitdefender — key questions answered
It means PACSEC3 cannot refile the same infringement claims based on US7523497B2 against Bitdefender. A dismissal with prejudice under Rule 41(a)(1)(B) operates as a final adjudication on the merits, triggering claim preclusion. Bitdefender is permanently shielded from this specific plaintiff on these specific claims, regardless of any future product development.
Under Fed. R. Civ. P. 41(a)(1)(A)(i), a plaintiff may dismiss an action without a court order by filing a notice of dismissal before the opposing party serves an answer or a motion for summary judgment. Bitdefender had done neither. The court confirmed the filing was self-effectuating — the case terminated automatically upon PACSEC3 filing its notice on September 11, 2025.
No. A voluntary dismissal — even with prejudice — does not constitute a finding of invalidity or unenforceability. US7523497B2 remains a granted, in-force US patent. PACSEC3 retains the right to assert it against any other defendant not covered by this dismissal. Other cybersecurity vendors with firewall products should treat the patent as an active enforcement risk.
The court’s costs order means neither party received a fee award under 35 U.S.C. § 285 (exceptional case) or Rule 54(d). This is the default outcome in most voluntary dismissals and does not imply the case was deemed frivolous or exceptional. It also suggests Bitdefender did not pursue — or did not succeed in — any fee-shifting motion before the case closed.
The public record for this case names PACSEC3, LLC as the sole plaintiff and Bitdefender as the sole defendant. Whether PACSEC3 or related entities have asserted this or related patents against other cybersecurity vendors cannot be confirmed from this single case record alone. However, Ramey LLP is a known high-volume patent assertion firm in W.D. Texas, and IP professionals in the network security sector should monitor related docket activity for US7523497B2 and associated patent families.
Don’t Wait for an Assertion Letter — Run Your FTO on US7523497B2 Now
US7523497B2 is an active firewall systems patent with demonstrated enforcement intent. Use PatSnap Eureka to map your product exposure, monitor PACSEC3’s portfolio activity, and build an IPR prior art file before litigation risk materialises.
PatSnap Eureka searches patents and litigation data to answer instantly.